Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LLY compared with ABUS: revenue, margins and what each company keeps, and the suppliers and customers both name
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
ABUS
Arbutus Biopharma Corp
Change
Mkt cap
Revenue
Revenue
vs
Compare
LLY
ELI Lilly & Co
vs
ABUS
Arbutus Biopharma Corp
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
LLY, solid
ABUS, dashed
LLY
ELI Lilly & Co
Change
1,385.16
▼
−2.32%
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
ABUS
Arbutus Biopharma Corp
Change
3.75
▼
−7.64%
Regular session
Nov 5 '26
Mkt cap
$803.3M
Revenue
$1M
Q2 FY26
Revenue
$14M
FY25
vs
Compare
Regular session
Nov 5 '26
LLY
ELI Lilly & Co
vs
ABUS
Arbutus Biopharma Corp
1,385.16
▼
−2.32%
Price
3.75
▼
−7.64%
$1.3T
Mkt cap
$803.3M
Q3 FY26
$24.4B
Revenue
$1M
Q2 FY26
FY25
$65.2B
Revenue
$14M
FY25
Change
Change
LLY
1,385.16
▼
−2.32%
vs
ABUS
3.75
▼
−7.64%
Regular session
Nov 5 '26